Patient-Specific Modeling of Diffuse Large B-Cell Lymphoma
Personalized medicine aims to tailor treatment to patients based on their individual genetic or molecular background. Especially in diseases with a large molecular heterogeneity, such as diffuse large B-cell lymphoma (DLBCL), personalized medicine has the potential to improve outcome and/or to reduc...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
MDPI AG
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/fa11e8ee04db491da78735748c189709 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|